Clinical Trial

Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this clinical study is to demonstrate the superior antihypersensitivity efficacy of a novel stannous fluoride (SnF2) and potassium nitrate (KNO3) dentifrice (Investigational Product), compared to SnF2 only, KNO3 only and Vehicle dentifrices, after 8 weeks twice daily use.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-17
notable Enrollment reduced: 850 -> 688 participants 2026-06-17
Trial Details
NCT Number NCT07215767
Lead Sponsor HALEON
Conditions Dentin Hypersensitivity
Enrollment 688 participants
Start Date 2025-09-16
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-16